Mylab is now a Harvard Business Review case study

Pune: Harvard Business Review Case Collection, one of the most prestigious institutes in the world, has included a case study on Mylab’s journey and its path-breaking innovations in the face of adversities. The case study is also included in the IIM-B curriculum.

The case study titled, ‘Mylab Discovery Solutions: Innovating against all Odds’ aptly summarises the company’s business challenges, innovative solutions, its vision of being ‘omnipresent’ and providing the ‘last mile diagnostic advantage’ to the patients. The case study highlights how Mylab had transitioned from a fledgling bio-technology start-up battling an array of challenges to a funded venture considering alternative strategies for sustaining growth. It also captures how the visionary founders steered Mylab through the COVID-19 pandemic taking their production from 10,000 tests to 550,000 per week and employee strength from 30 to 350.

The case study is prepared by Charu Rastogi (PhD student at IIMB), Professor Srivardhini K Jha (IIMB) and Rishikesha Krishnan (Director, IIMB).

Hasmukh Rawal, MD, Mylab said, “It makes us immensely happy and proud that Mylab’s journey and its innovation driven approach to transform healthcare, has led to it being included as a case study at the prestigious Harvard Business Review. We sincerely hope that our case study will inspire the entrepreneurs and future leaders to follow their dreams and carve their path of success.”

Commenting on the accomplishment, Sujit Jain, director of strategy, Mylab, said, “It is an honour for us to be a part of Harvard Business Review’s case collection. Mylab has made a significant contribution to the healthcare industry in the past decade. The company continues to present breakthrough solutions for the benefit of people, healthcare providers, and society, paving the way for a healthier tomorrow.”

Harvard case studies help refine the skills and business judgment of tens of thousands of students, practitioners, and academics across the world.